We are live on ! Find out more
FNHC

FedNat Holding Company Common Stock

Delisted

FNHC was delisted on the 4th of November, 2022.

2 hedge funds and large institutions have $0 invested in FedNat Holding Company Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 252 (-23)

100% less capital invested

Capital invested by funds: $212K → $0 (-$212K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

Holders
2
Holders Change
-23
Holders Change %
-92%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
Closed
22
Calls
Puts
Net Calls
Net Calls Change

FNHC Hedge Fund Activity: Q4 2022 in Review

2 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in FedNat Holding Company Common Stock (FNHC) for Q4 2022, worth a combined $0 — down 100% from $212K a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of FNHC and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Simplex Trading, adding an estimated $2.62K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $66K sold.

  • 2 institutional investors held FedNat Holding Company Common Stock (FNHC) as of Q4 2022, down from 25 in Q3 2022.
  • Funds reported $0 of FedNat Holding Company Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new FedNat Holding Company Common Stock positions in Q4 2022 and 22 closed out, a net change of -22 holders.
  • The largest FedNat Holding Company Common Stock buyer in Q4 2022 was Simplex Trading, an estimated $2.62K added.
  • The largest FedNat Holding Company Common Stock seller in Q4 2022 was Renaissance Technologies, an estimated $66K sold.

Based on aggregated 13F filings for Q4 2022.